ELMED Life Sciences Raises $2.7M Series A to Scale Probiotic…

Team S · 2026-03-26T14:35:47.000Z

Bengaluru-based biotech company ELMED Life Sciences has raised $2.7 million (₹25 crore) in Series A funding from AgriSURE Fund, an agri-focused investment fund managed by NABVENTURES, the venture capital arm of NABARD. Founded by Pruthivin Reddy Madduri and co-founded by Nikhil Konkathi, the company focuses on developing probiotic and biological solutions across animal health, aquaculture, agriculture, and human health. Its offerings are designed to improve productivity, immunity, and sustainability across farm ecosystems, addressing the growing demand for antibiotic-free and residue-free solutions. The funding will be used to expand manufacturing capacity, strengthen research and development in microbiome-based solutions, and scale distribution across key domestic and international markets. The company is also planning to deepen its reach in Tier 2 and Tier 3 markets in India, while expanding its global footprint across Europe, Asia, and Latin America. ELMED currently operates from Hyderabad and exports to over 18 countries, positioning itself as a key player in the rapidly growing biologicals and probiotics segment. The investment comes amid a broader shift in agriculture toward sustainable farming practices, driven by regulatory restrictions on antibiotics and increasing global demand for clean, residue-free produce.

Member Login Get Access

ELMED Life Sciences Raises $2.7M Series A to Scale Probiotic… | Newnex